<DOC>
	<DOCNO>NCT00899912</DOCNO>
	<brief_summary>RATIONALE : Collecting store sample tissue patient cancer study laboratory may help doctor learn change may occur DNA radiation therapy identify biomarkers related cancer . PURPOSE : This laboratory study look change DNA radiation therapy patient prostate cancer .</brief_summary>
	<brief_title>Changes DNA After Radiation Therapy Patients With Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Demonstrate feasibility acquire specimen , frozen paraffin-embedded , yield RNA adequate quality perform DNA microarray study marker radiotherapy outcome patient intermediate-risk prostate cancer . Secondary - Compare gene expression result frozen tissue paraffin-embedded tissue see correlation 2 method patient treat brachytherapy alone arm protocol RTOG-0232 . - Find gene express differentially radiation therapy patient treat brachytherapy plus external-beam radiation therapy arm protocol RTOG-0232 . - Find gene expression pattern patient treat either arm protocol RTOG-0232 significant association biochemically well clinically apparent local distant failure . OUTLINE : This multicenter , pilot study . Frozen paraffin-embedded tissue sample study biomarker/laboratory analysis . DNA microarray analysis perform sample assess marker radiotherapy outcome . PROJECTED ACCRUAL : A total 156 patient accrue study .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Histologically confirm , locally confine adenocarcinoma prostate Zubrod performance 01 Clinical stage T1c T2b , N0 , M0 Combined Gleason score 7 prostate specific antigen ( PSA ) &lt; 10 , combine Gleason score &lt; 7 PSA 10 20 ; PSA must ≤ 20 ng/mL , hormone therapy , give , prostate volume transrectal ultrasound ( TRUS ) ≤ 60 cc . American Urological Association ( AUA ) score ≤ 15 ( alpha blocker allow ) . Age ≥ 18 year old must sign studyspecific inform consent form No clinically pathologically involved lymph nod No distant metastasis significant obstructive symptom No prior chemotherapy , pelvic radiation , transurethral prostatectomy ( TURP ) , cryosurgery , TUNA , transurethral microwave thermotherapy ( TUMT ) radical surgery carcinoma prostate allow . No previous hormonal therapy begin &lt; 2 month &gt; 6 month prior registration allow . No previous concurrent cancer basal , situ , squamous cell skin cancer unless patient disease free ≥ 5 year . No hip prosthesis major medical psychiatric illness allow . prior study entry .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>adenocarcinoma prostate</keyword>
</DOC>